Basic Stats
| LEI | 8945004Z7ZHV3LML4J27 |
| CIK | 1835539 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Olink Holding AB (publ) - Depositary Receipt (Common Stock)
SEC Filings (Chronological Order)
This page provides a complete, chronological list of SEC Filings, excluding ownership filings which we provide elsewhere.
| July 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact name of registrant as specified in |
|
| July 22, 2024 |
Uppsala, in July 2024 Olink Holding AB (publ) The Board of Directors Exhibit 99.1 To the shareholders of Olink Holding AB (publ) Orion Acquisition AB (the "Majority Shareholder") owns in total more than nine-tenths of the shares in Olink Holding AB (publ) (reg. no. 559189-7755) ("Olink"). According to Chapter 22, Section 1 of the Swedish Companies Act (2005:551), the Majority Shareholder is therefore entitled to redeem the remaining shares from the other shareholde |
|
| July 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Salagatan 16A SE-753 30 Uppsala, Sweden (Address of principal execu |
|
| July 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 15) Olink Holding AB (publ) (Name of Subject Company) Olink Holding AB (publ) (Name of Person Filing Statement) American Depositary Shares, each representing one Common Share, quota v |
|
| July 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 20) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 OLINK HOLDING AB (PUBL) (Name of Subject Company (Issuer)) ORION ACQUISITION AB (Offeror) a direct, wholly owned subsidiary of THERMO FISHER SCIENTIFIC INC. (Ultimate Parent of Offeror) Common Shares, |
|
| July 11, 2024 |
Uppsala in July 2024 The Board of Directors Olink Holding AB (publ) Exhibit 99.1 This is a translation of the Swedish original. In case of any discrepancies between this translation and the Swedish original, the latter shall prevail. Notice to attend the Extra General Meeting of Olink Holding AB (publ) The shareholders of Olink Holding AB (publ) (the "Company"), reg. no. 559189-7755, are hereby given notice to attend the Extra General Meeting to be held at 4:00 p. |
|
| July 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Salagatan 16A SE-753 30 Uppsala, Sweden (Address of principal execu |
|
| July 10, 2024 |
As filed with the Securities and Exchange Commission on July 10, 2024 As filed with the Securities and Exchange Commission on July 10, 2024 Registration No. |
|
| July 10, 2024 |
As filed with the Securities and Exchange Commission on July 10, 2024 As filed with the Securities and Exchange Commission on July 10, 2024 Registration No. |
|
| July 10, 2024 |
Exhibit (a)(5)(W) FOR IMMEDIATE RELEASE Media Contact Information: Sandy Pound Investor Contact Information: Rafael Tejada Phone: 781-622-1223 Phone: 781-622-1356 E-mail: sandy. |
|
| July 10, 2024 |
As filed with the Securities and Exchange Commission on July 10, 2024 As filed with the Securities and Exchange Commission on July 10, 2024 Registration No. |
|
| July 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 19) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 OLINK HOLDING AB (PUBL) (Name of Subject Company (Issuer)) ORION ACQUISITION AB (Offeror) a direct, wholly owned subsidiary of THERMO FISHER SCIENTIFIC INC. (Ultimate Parent of Offeror) Common Shares, |
|
| July 10, 2024 |
As filed with the Securities and Exchange Commission on July 10, 2024 As filed with the Securities and Exchange Commission on July 10, 2024 Registration No. |
|
| July 10, 2024 |
As filed with the Securities and Exchange Commission on July 10, 2024 As filed with the Securities and Exchange Commission on July 10, 2024 Registration No. |
|
| July 10, 2024 |
Dear Shareholders and Market Participants, Exhibit (a)(5)(X) Dear Shareholders and Market Participants, Thermo Fisher Scientific has today announced the commencement of a subsequent offering period in order to allow any remaining shareholders accept the offer for the common shares of Olink. |
|
| July 10, 2024 |
Exhibit (a)(5)(T) FOR IMMEDIATE RELEASE Media Contact Information: Sandy Pound Investor Contact Information: Rafael Tejada Phone: 781-622-1223 Phone: 781-622-1356 E-mail: sandy. |
|
| July 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Salagatan 16A SE-753 30 Uppsala, Sweden (Address of principal execu |
|
| July 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 14) Olink Holding AB (publ) (Name of Subject Company) Olink Holding AB (publ) (Name of Person Filing Statement) American Depositary Shares, each representing one Common Share, quota v |
|
| July 10, 2024 |
Exhibit (a)(1)(I) Acceptance Form for the Subsequent Offering Period by Orion Acquisition AB to shareholders in Olink Holding AB (publ) Shareholders of Common Shares, ISIN: SE0015797568 Please submit this Acceptance form to: DNB Markets, a part of DNB Bank ASA, Sweden Branch Regeringsgatan 59, 105 88 Stockholm, Sweden DNB Markets, Securities Services at emissioner@dnb. |
|
| July 8, 2024 |
Olink Announces Receipt of CMA Clearance for Proposed Acquisition by Thermo Fisher Exhibit (a)(5)(S) Olink Announces Receipt of CMA Clearance for Proposed Acquisition by Thermo Fisher Uppsala, Sweden, July 8, 2024 - Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that the UK Competition and Markets Authority (the “CMA”) has unconditionally approved the previously announced tender offer (the “Offer”) by Orion Acquisition AB (the “Buyer”), a wholly owned subsidiary of Thermo Fisher Scientific Inc. |
|
| July 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 13) Olink Holding AB (publ) (Name of Subject Company) Olink Holding AB (publ) (Name of Person Filing Statement) American Depositary Shares, each representing one Common Share, quota v |
|
| July 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 12) Olink Holding AB (publ) (Name of Subject Company) Olink Holding AB (publ) (Name of Person Filing Statement) American Depositary Shares, each representing one Common Share, quota v |
|
| July 5, 2024 |
Report from the Extra General Meeting of Olink Holding AB (publ) on 5 July 2024 Exhibit 99.1 Press release 5 July 2024 Report from the Extra General Meeting of Olink Holding AB (publ) on 5 July 2024 At the Extra General Meeting (the “EGM”) of Olink Holding AB (publ), reg. no 559189-7755 (the “Company”), the EGM adopted, inter alia, the following resolutions. For more detailed information regarding the contents of the resolutions, please refer to the notice to the EGM and the |
|
| July 5, 2024 |
Exhibit (e)(29) CONTRACT OF EMPLOYMENT CONTRACT DATE: July 1st 2024 BETWEEN: 1. OLINK PROTEOMICS LIMITED of 24 Old Queen Street, London, SW1H 9HP, United Kingdom ("the Company") 2. LINDA RAMIREZ-EAVES of 33 Marlborough Road, Richmond, TW10 6JT, United Kingdom (“the Employee”) It is agreed that the Company will employ you upon and subject to the following terms and conditions. For the avoidance of |
|
| July 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Salagatan 16F SE-75330 Uppsala, Sweden (Address of principal execut |
|
| June 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 11) Olink Holding AB (publ) (Name of Subject Company) Olink Holding AB (publ) (Name of Person Filing Statement) American Depositary Shares, each representing one Common Share, quota v |
|
| June 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 18) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 OLINK HOLDING AB (PUBL) (Name of Subject Company (Issuer)) ORION ACQUISITION AB (Offeror) a direct, wholly owned subsidiary of THERMO FISHER SCIENTIFIC INC. (Ultimate Parent of Offeror) Common Shares, |
|
| June 20, 2024 |
Exhibit (a)(5)(V) FOR IMMEDIATE RELEASE Media Contact Information: Sandy Pound Investor Contact Information: Rafael Tejada Phone: 781-622-1223 Phone: 781-622-1356 E-mail: sandy. |
|
| June 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2024 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Salagatan 16F SE-75330 Uppsala, Sweden (Address of principal execut |
|
| June 11, 2024 |
Exhibit 99.1 This is a translation of the Swedish original. In case of any discrepancies between this translation and the Swedish original, the latter shall prevail. Notice to attend the Extra General Meeting of Olink Holding AB (publ) The shareholders of Olink Holding AB (publ) (the “Company”), reg. no. 559189-7755, are hereby given notice to attend the Extra General Meeting to be held at 4:00 p. |
|
| May 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 17) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 OLINK HOLDING AB (PUBL) (Name of Subject Company (Issuer)) ORION ACQUISITION AB (Offeror) a direct, wholly owned subsidiary of THERMO FISHER SCIENTIFIC INC. (Ultimate Parent of Offeror) Common Shares, |
|
| May 14, 2024 |
Exhibit (a)(5)(U) The following is an excerpt from the transcript of Thermo Fisher’s CEO remarks given on May 14, 2024 at the Bank of America Securities 2024 Health Care Conference: [W]e're looking forward first to finishing the regulatory process in Olink, and we're on track for the middle of the year. . . . I'm just excited to welcome the colleagues and have that offering for our customers. * * * |
|
| May 13, 2024 |
Olink reports first quarter 2024 financial results Exhibit 99.1 Olink reports first quarter 2024 financial results UPPSALA, Sweden, May 13, 2024 (GLOBE NEWSWIRE) - Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial results for the first quarter ended March 31, 2024. Highlights •First quarter 2024 revenue totaled $28.8 million, representing year over year growth of 5% on a reported basis and 5% on a constant cur |
|
| May 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Salagatan 16A SE-753 30 Uppsala, Sweden (Address of principal execut |
|
| May 13, 2024 |
Exhibit 99.2 INTERIM CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND OTHER COMPREHENSIVE INCOME (UNAUDITED) Three months ended March 31, Amounts in thousands of U.S. Dollars Note 2024 2023 Revenue 4 $ 28,751 $ 27,457 Cost of revenue (11,306) (9,843) Gross profit 17,445 17,614 Selling expenses (13,903) (11,995) Administrative expenses (19,459) (16,381) Research and development expenses (10,459) (6, |
|
| May 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 10) Olink Holding AB (publ) (Name of Subject Company) Olink Holding AB (publ) (Name of Person Filing Statement) American Depositary Shares, each representing one Common Share, quota v |
|
| May 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 16) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 OLINK HOLDING AB (PUBL) (Name of Subject Company (Issuer)) ORION ACQUISITION AB (Offeror) a direct, wholly owned subsidiary of THERMO FISHER SCIENTIFIC INC. (Ultimate Parent of Offeror) Common Shares, |
|
| May 1, 2024 |
Olink Tender Offer Extension Employee Letter from Olink CEO Exhibit (a)(5)(Q) Olink Tender Offer Extension Employee Letter from Olink CEO May 1, 2024 Dear Colleagues, I would like to update you on recent developments in our agreement to combine with Thermo Fisher Scientific. |
|
| May 1, 2024 |
Exhibit (a)(5)(T) FOR IMMEDIATE RELEASE Media Contact Information: Sandy Pound Investor Contact Information: Rafael Tejada Phone: 781-622-1223 Phone: 781-622-1356 E-mail: sandy. |
|
| April 24, 2024 |
Exhibit (a)(5)(S) The following is an excerpt from the transcript of Thermo Fisher’s First Quarter Earnings Call held on April 24, 2024: Turning to our planned acquisition of Olink, we’re working through the regulatory process and the transaction is on track to close by mid-2024. We look forward to welcoming our new colleagues to the company later this year. * * * |
|
| April 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 15) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 OLINK HOLDING AB (PUBL) (Name of Subject Company (Issuer)) ORION ACQUISITION AB (Offeror) a direct, wholly owned subsidiary of THERMO FISHER SCIENTIFIC INC. (Ultimate Parent of Offeror) Common Shares, |
|
| April 19, 2024 |
Exhibit 107 Calculation of Filing Fee Table S-8 (Form Type) Olink Holding AB (publ) (Exact Name of Registrant as Specified in its Charter) Table 1—Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Shares, quota value approx. |
|
| April 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Salagatan 16F SE-75330 Uppsala, Sweden (Address of principal execu |
|
| April 19, 2024 |
As filed with the Securities and Exchange Commission on April 19, 2024 As filed with the Securities and Exchange Commission on April 19, 2024 Registration No. |
|
| April 19, 2024 |
Report from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024 Exhibit 99.1 Press release 19 April 2024 Report from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024 At the Annual General Meeting (the “AGM”) of Olink Holding AB (publ), reg. no 559189-7755, (the “Company”), on 19 April 2024 the AGM adopted, inter alia, the following resolutions. For more detailed information regarding the contents of the resolutions, please refer to the no |
|
| April 19, 2024 |
Second Amendment to Olink Holding AB (publ) Amended and Restated 2021 Incentive Award Plan Exhibit 99.3 Second Amendment to Olink Holding AB (publ) Amended and Restated 2021 Incentive Award Plan This Second Amendment to Olink Holding AB (publ) Amended and Restated 2021 Incentive Award Plan (this “Second Amendment”), made as of 14 March 2024, is made and adopted by Olink Holding AB (publ), a Swedish public limited liability company (the “Company”). Capitalized terms used but not otherwis |
|
| March 25, 2024 |
Consent of Independent Registered Public Accounting Firm Exhibit 15.1 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the following Registration Statements: •Registration Statement (Form S-8 No. 333-254844) •Registration Statement (Form S-8 No. 333-264181) •Registration Statement (Form F-3 No. 333-269285) •Registration Statement (Form S-8 No. 333-271290) of our reports dated March 25, 2024, with r |
|
| March 25, 2024 |
limitation failure to properly perform routine maintenance and maintain the Instrument site in accordance with Fluidigm’s requirements or the use of the Product with any non- Fluidigm product (except as they may be specifically validated by Olink or Fluidigm, with respect to standard laboratory reagents, consumables, tools and equipment ancillary to use of the Product), (ii) has been repaired, alt |
|
| March 25, 2024 |
DocuSign Envelope ID: 55E92D28-CE56-49DA-97CC-5D28F616C5BE AMENDMENT NO. 7 TO OEM SUPPLY & DEVELOPMENT AGREEMENT Amendment No. 7 to OEM Supply & Development Agreement (the "Amendment"), between Olink Proteomics AB, a Swedish corporation with its principal place of business at Dag Hammarskjöld vag 52B, SE-752 37 Uppsala, Sweden ("Olink"), and Standard BioTools Inc. (formerly known as Fluidigm Corpo |
|
| March 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Salagaten 16A SE-753 30 Uppsala, Sweden (Address of principal exec |
|
| March 25, 2024 |
AMENDMENT NO. 4 TO OEM SUPPLY & DEVELOPMENT AGREEMENT Amendment No. 4 to OEM Supply & Development Agreement (the "Amendment"), between Olink Proteomics AB, a Swedish corporation with its principal place of business at Dag Hammarskjöld vag 52B, SE-752 37 Uppsala, Sweden ("Olink"), and Fluidigm Corporation, a Delaware corporation organized and existing under the laws of the United States of America, |
|
| March 25, 2024 |
DocuSign Envelope ID: B594FC2C-FC13-46EB-9861-E582CB82E09B First Amendment to Olink Holding AB (publ) Amended and Restated 2021 Incentive Award Plan This First Amendment to Olink Holding AB (publ) Amended and Restated 2021 Incentive Award Plan (this “First Amendment”), made as of 14 March 2023, is made and adopted by Olink Holding AB (publ), a Swedish public limited liability company (the “Company”). |
|
| March 25, 2024 |
Certification by the Principal Financial Officer pursuant to Exhibit 13.2 Certification by the Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the annual report on Form 20-F of Olink Holding AB (publ) (the “Company”) for the year ended December 31, 2023, as filed with the U.S. Securities and Exchange Commission on the date hereof (the “Report”), I, Oskar |
|
| March 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT O |
|
| March 25, 2024 |
Olink publishes 2023 annual report Exhibit 99.3 Olink publishes 2023 annual report UPPSALA, Sweden, March 25, 2024 (GLOBE NEWSWIRE) - Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that the Annual Report for 2023 is now available on the Company’s website at https://investors.olink.com/. About Olink Olink Holding AB (Nasdaq: OLK) is a company dedicated to accelerating proteomics together with the scientific communit |
|
| March 25, 2024 |
DocuSign Envelope ID: 530C9DF2-3B27-4865-9BFB-8BDC2388C913 AMENDMENT NO. 8 TO OEM SUPPLY & DEVELOPMENT AGREEMENT Amendment No. 8 to OEM Supply & Development Agreement (the "Amendment"), between Olink Proteomics AB, a Swedish corporation with its principal place of business at Dag Hammarskjölds vag 52B, SE-752 37 Uppsala, Sweden ("Olink"), and Standard BioTools Inc. (formerly known as Fluidigm Corp |
|
| March 25, 2024 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 15.3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (No. 333-269285) and Form S 8 (Nos.333-271290, 333-264181 and 333-254844) of Olink Holding AB (publ) of our report dated March 17, 2022 relating to the financial statements, which appears in this Form 20-F. /s/ Öhrlings Pricewaterhouse |
|
| March 25, 2024 |
Olink reports fourth quarter and full year 2023 financial results Exhibit 99.1 Olink reports fourth quarter and full year 2023 financial results UPPSALA, Sweden, March 25, 2024 (GLOBE NEWSWIRE) - Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial results for the fourth quarter ended December 31, 2023. Highlights •Fourth quarter 2023 revenue totaled $68.6 million, representing year over year growth of 18% on a reported basis a |
|
| March 25, 2024 |
Exhibit 12.2 Certification by the Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Oskar Hjelm, certify that: 1.I have reviewed this annual report on Form 20-F of Olink Holding AB (publ) (the “Company”); 2.Based on my knowledge, this report does not contain any untrue statement of a |
|
| March 25, 2024 |
Description of Securities DESCRIPTION OF SHARE CAPITAL AND ARTICLES OF ASSOCIATION Exhibit 2.5 Description of Securities DESCRIPTION OF SHARE CAPITAL AND ARTICLES OF ASSOCIATION Introduction Set forth below is a summary of certain information concerning Olink Holding AB (publ)'s (“us,” “our,” “we” or the “Company”) share capital as well as a description of certain provisions of our articles of association and relevant provisions of the Swedish Companies Act (Sw. Aktiebolagslagen |
|
| March 25, 2024 |
Exhibit 99.2 The Board of Directors and the CEO of Olink Holding AB (publ) Corporate identity number 559189-7755 submit the following Annual report and consolidated financial statements for the financial year 1 January – 31 December 2023 Olink Holding AB (publ) 559189-7755 Financial statements Directors’ report 2 Consolidated statement of income and other comprehensive income for the year ended De |
|
| March 25, 2024 |
www.olink.com Olink Proteomics, Dag Hammarskjölds väg 52B Uppsala Science Park, SE-751 83 Uppsala, Sweden Phone: +46 (0)18 444 39 70, [email protected], Reg no: 559046-8632 1 Executive Officer Incentive Compensation Recovery Policy Document Owner Document Holder Remuneration Committee General Counsel Approval Board of Directors of Olink Holding AB (publ) (the “Company” and together with its subsidiar |
|
| March 25, 2024 |
Certification by the Principal Executive Officer pursuant to Exhibit 13.1 Certification by the Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the annual report on Form 20-F of Olink Holding AB (publ) (the “Company”) for the year ended December 31, 2023, as filed with the U.S. Securities and Exchange Commission on the date hereof (the “Report”), I, Jon He |
|
| March 25, 2024 |
Exhibit 12.1 Certification by the Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Jon Heimer, certify that: 1.I have reviewed this annual report on Form 20-F of Olink Holding AB (publ) (the “Company”); 2.Based on my knowledge, this report does not contain any untrue statement of a |
|
| March 25, 2024 |
DocuSign Envelope ID: 9E9E7F5C-C117-4B88-AA76-E4E4C42223EE AMENDMENT NO. 6 TO OEM SUPPLY & DEVELOPMENT AGREEMENT Amendment No. 6 to OEM Supply & Development Agreement (the "Amendment"), between Olink Proteomics AB, a Swedish corporation with its principal place of business at Dag Hammarskjöld vag 52B, SE-752 37 Uppsala, Sweden ("Olink"), and Standard BioTools Inc. (formerly known as Fluidigm Corpo |
|
| March 15, 2024 |
Uppsala in March 2024 The Board of Directors Olink Holding AB (publ) Exhibit 99.1 This is a translation of the Swedish original. In case of any discrepancies between this translation and the Swedish original, the latter shall prevail. Notice to attend the Annual General Meeting of Olink Holding AB (publ) UPPSALA, Sweden, March 15, 2024 - The shareholders of Olink Holding AB (publ) (the “Company” or “Olink”), reg. no. 559189-7755, are hereby given notice to attend t |
|
| March 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Salagaten 16A SE-753 30 Uppsala, Sweden (Address of principal exec |
|
| March 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Salagaten 16A SE-753 30 Uppsala, Sweden (Address of principal exec |
|
| March 6, 2024 |
Exhibit (a)(5)(R) The following is an excerpt from the transcript of Thermo Fisher’s CEO remarks given on March 6, 2024 at the TD Cowen 44th Annual Health Care Conference: I’m very excited about Olink. |
|
| March 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 14) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 OLINK HOLDING AB (PUBL) (Name of Subject Company (Issuer)) ORION ACQUISITION AB (Offeror) a direct, wholly owned subsidiary of THERMO FISHER SCIENTIFIC INC. (Ultimate Parent of Offeror) Common Shares, |
|
| March 1, 2024 |
Exhibit (a)(5)(Q) FOR IMMEDIATE RELEASE Media Contact Information: Sandy Pound Investor Contact Information: Rafael Tejada Phone: 781-622-1223 Phone: 781-622-1356 E-mail: sandy. |
|
| March 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 13) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 OLINK HOLDING AB (PUBL) (Name of Subject Company (Issuer)) ORION ACQUISITION AB (Offeror) a direct, wholly owned subsidiary of THERMO FISHER SCIENTIFIC INC. (Ultimate Parent of Offeror) Common Shares, |
|
| March 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 9) Olink Holding AB (publ) (Name of Subject Company) Olink Holding AB (publ) (Name of Person Filing Statement) American Depositary Shares, each representing one Common Share, quota va |
|
| February 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 8) Olink Holding AB (publ) (Name of Subject Company) Olink Holding AB (publ) (Name of Person Filing Statement) American Depositary Shares, each representing one Common Share, quota va |
|
| February 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 12) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 OLINK HOLDING AB (PUBL) (Name of Subject Company (Issuer)) ORION ACQUISITION AB (Offeror) a direct, wholly owned subsidiary of THERMO FISHER SCIENTIFIC INC. (Ultimate Parent of Offeror) Common Shares, |
|
| January 31, 2024 |
Exhibit (a)(5)(P) The following is an excerpt from the transcript of Thermo Fisher’s Fourth Quarter and Full Year 2023 earnings call held on January 31, 2024: During the fourth quarter, we announced our intent to acquire Olink, a provider of advanced proteomics solutions that help researchers to gain an understanding of disease at the protein level rapidly and efficiently. |
|
| January 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 11) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 OLINK HOLDING AB (PUBL) (Name of Subject Company (Issuer)) ORION ACQUISITION AB (Offeror) a direct, wholly owned subsidiary of THERMO FISHER SCIENTIFIC INC. (Ultimate Parent of Offeror) Common Shares, |
|
| January 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Salagaten 16A SE-753 30 Uppsala, Sweden (Address of principal ex |
|
| January 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 10) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 OLINK HOLDING AB (PUBL) (Name of Subject Company (Issuer)) ORION ACQUISITION AB (Offeror) a direct, wholly owned subsidiary of THERMO FISHER SCIENTIFIC INC. (Ultimate Parent of Offeror) Common Shares, |
|
| January 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 7) Olink Holding AB (publ) (Name of Subject Company) Olink Holding AB (publ) (Name of Person Filing Statement) American Depositary Shares, each representing one Common Share, quota va |
|
| January 4, 2024 |
Exhibit (a)(5)(O) FOR IMMEDIATE RELEASE Media Contact Information: Sandy Pound Investor Contact Information: Rafael Tejada Phone: 781-622-1223 Phone: 781-622-1356 E-mail: sandy. |
|
| December 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 9) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 OLINK HOLDING AB (PUBL) (Name of Subject Company (Issuer)) ORION ACQUISITION AB (Offeror) a direct, wholly owned subsidiary of THERMO FISHER SCIENTIFIC INC. (Ultimate Parent of Offeror) Common Shares, |
|
| December 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 6) Olink Holding AB (publ) (Name of Subject Company) Olink Holding AB (publ) (Name of Person Filing Statement) American Depositary Shares, each representing one Common Share, quota va |
|
| December 15, 2023 |
Exhibit (a)(5)(N) FOR IMMEDIATE RELEASE Media Contact Information: Sandy Pound Investor Contact Information: Rafael Tejada Phone: 781-622-1223 Phone: 781-622-1356 E-mail: sandy. |
|
| December 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 4) Olink Holding AB (publ) (Name of Subject Company) Olink Holding AB (publ) (Name of Person Filing Statement) American Depositary Shares, each representing one Common Share, quota va |
|
| December 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 8) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 OLINK HOLDING AB (PUBL) (Name of Subject Company (Issuer)) ORION ACQUISITION AB (Offeror) a direct, wholly owned subsidiary of THERMO FISHER SCIENTIFIC INC. (Ultimate Parent of Offeror) Common Shares, |
|
| December 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 5) Olink Holding AB (publ) (Name of Subject Company) Olink Holding AB (publ) (Name of Person Filing Statement) American Depositary Shares, each representing one Common Share, quota va |
|
| December 14, 2023 |
December 14, 2023 Via Edgar U.S. Securities and Exchange Commission Division of Corporation Finance Office of Mergers and Acquisitions 100 F Street, N.E. Washington, D.C. 20549 Attention: Christina Chalk, Shane Callaghan and Eddie Kim Re: Olink Holding AB (publ) Schedule 14D-9 Filed October 31, 2023 File No. 005-93360 Ladies and Gentlemen: This letter sets forth the response of Olink Holding AB (p |
|
| December 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 7) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 OLINK HOLDING AB (PUBL) (Name of Subject Company (Issuer)) ORION ACQUISITION AB (Offeror) a direct, wholly owned subsidiary of THERMO FISHER SCIENTIFIC INC. (Ultimate Parent of Offeror) Common Shares, |
|
| December 5, 2023 |
Goldman Sachs Bank Europe SE, Sweden Bankfilial Exhibit (a)(5)(B) Goldman Sachs Bank Europe SE, Sweden Bankfilial Blasieholmsgatan 7 1111 48 Stockholm I Sweden Tel: +46 (0)8 407 4900 PERSONAL AND CONFIDENTIAL October 17, 2023 Board of Directors Olink Holding AB (publ) Uppsala Science Park SE-751 83 Uppsala Sweden Ladies and Gentlemen: You have requested our opinion as to the fairness from a financial point of view to the holders (other than Thermo Fisher Scientific Inc. |
|
| December 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 3) Olink Holding AB (publ) (Name of Subject Company) Olink Holding AB (publ) (Name of Person Filing Statement) American Depositary Shares, each representing one Common Share, quota va |
|
| December 4, 2023 |
December 4, 2023 Via Edgar U.S. Securities and Exchange Commission Division of Corporation Finance Office of Industrial Application and Services 100 F Street, N.E. Washington, D.C. 20549 Attention: Al Pavot and Jeanne Baker Re: Olink Holding AB (publ) Schedule 14D-9 Filed October 31, 2023 File No. 005-93360 Ladies and Gentlemen: This letter sets forth the response of Olink Holding AB (publ) (the “ |
|
| December 1, 2023 |
TABLE OF CONTENTS Exhibit (a)(1)(H) AMENDED AND RESTATED OFFER TO PURCHASE FOR CASH All Outstanding Common Shares and All Outstanding American Depositary Shares, each representing one Common Share, of Olink Holding AB (publ) at $26. |
|
| December 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 5) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 OLINK HOLDING AB (PUBL) (Name of Subject Company (Issuer)) ORION ACQUISITION AB (Offeror) a direct, wholly owned subsidiary of THERMO FISHER SCIENTIFIC INC. (Ultimate Parent of Offeror) Common Sh |
|
| December 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 6) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 OLINK HOLDING AB (PUBL) (Name of Subject Company (Issuer)) ORION ACQUISITION AB (Offeror) a direct, wholly owned subsidiary of THERMO FISHER SCIENTIFIC INC. (Ultimate Parent of Offeror) Common Shares, |
|
| December 1, 2023 |
Exhibit (a)(5)(M) FOR IMMEDIATE RELEASE Media Contact Information: Sandy Pound Investor Contact Information: Rafael Tejada Phone: 781-622-1223 Phone: 781-622-1356 E-mail: sandy. |
|
| November 15, 2023 |
Three months ended September 30, Exhibit 99.2 INTERIM CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND OTHER COMPREHENSIVE INCOME (UNAUDITED) Three months ended September 30, Nine months ended September 30, Amounts in thousands of U.S. Dollars Note 2023 2022 2023 2022 Revenue 4 $ 44,152 $ 31,772 $ 101,045 $ 81,963 Cost of goods sold (13,265) (10,785) (35,253) (30,589) Gross profit 30,887 20,987 65,792 51,374 Selling expenses (14,2 |
|
| November 15, 2023 |
Olink reports third quarter 2023 financial results Exhibit 99.1 Olink reports third quarter 2023 financial results UPPSALA, Sweden, November 15, 2023 (GLOBE NEWSWIRE) - Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial results for the third quarter ended September 30, 2023. Highlights •Third quarter 2023 revenue totaled $44.2 million, representing year over year growth of 39% on a reported basis and 38% on a c |
|
| November 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2023 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Salagaten 16A SE-753 30 Uppsala, Sweden (Address of principal e |
|
| November 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 4) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 OLINK HOLDING AB (PUBL) (Name of Subject Company (Issuer)) ORION ACQUISITION AB (Offeror) a direct, wholly owned subsidiary of THERMO FISHER SCIENTIFIC INC. (Ultimate Parent of Offeror) Common Shares, |
|
| November 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2) Olink Holding AB (publ) (Name of Subject Company) Olink Holding AB (publ) (Name of Person Filing Statement) American Depositary Shares, each representing one Common Share, quota va |
|
| November 13, 2023 |
Message to Current and Former Employees with Global Share Accounts: Exhibit (a)(5)(K) Message to Current and Former Employees with Global Share Accounts: Orion Acquisition AB (“Buyer”), a direct, wholly owned subsidiary of Thermo Fisher Scientific Inc. |
|
| November 13, 2023 |
Olink Holding AB (publ) Employee Frequently Asked Questions Exhibit (a)(5)(I) Olink Holding AB (publ) Employee Frequently Asked Questions 1. What is the tender offer? The “tender offer” is a public bid for shareholders of Olink Holding AB (publ) (“Olink”) to sell their Olink common shares (“Common Shares”) and American Depositary Shares (which each represent one Common Share) (“ADSs”), to Thermo Fisher Scientific Inc., a Delaware corporation (“Thermo Fishe |
|
| November 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1) Olink Holding AB (publ) (Name of Subject Company) Olink Holding AB (publ) (Name of Person Filing Statement) American Depositary Shares, each representing one Common Share, quota va |
|
| November 13, 2023 |
Email to Current and Former Employees with Global Share Accounts: Exhibit (a)(5)(L) Email to Current and Former Employees with Global Share Accounts: Orion Acquisition AB (“Buyer”), a direct, wholly owned subsidiary of Thermo Fisher Scientific Inc. |
|
| November 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 3) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 OLINK HOLDING AB (PUBL) (Name of Subject Company (Issuer)) ORION ACQUISITION AB (Offeror) a direct, wholly owned subsidiary of THERMO FISHER SCIENTIFIC INC. (Ultimate Parent of Offeror) Common Shares, |
|
| November 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 2) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 OLINK HOLDING AB (PUBL) (Name of Subject Company (Issuer)) ORION ACQUISITION AB (Offeror) a direct, wholly owned subsidiary of THERMO FISHER SCIENTIFIC INC. (Ultimate Parent of Offeror) Common Shares, |
|
| November 6, 2023 |
Exhibit (a)(5)(J) Dear nominees and other market participants holding Olink Holding AB (publ) common shares, ISIN SE0015797568 Reference is made to the previously announced tender offer (the “Offer”) by Orion Acquisition AB for all the outstanding common shares and ADSs of Olink Holding AB (publ), which was commenced on October 31, 2023. |
|
| November 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 1) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 OLINK HOLDING AB (PUBL) (Name of Subject Company (Issuer)) ORION ACQUISITION AB (Offeror) a direct, wholly owned subsidiary of THERMO FISHER SCIENTIFIC INC. (Ultimate Parent of Offeror) Common Shares, |
|
| November 2, 2023 |
Exhibit (a)(5)(I) Aktuella Transaktioner Public Tender Offer to Shareholders in Olink Holding AB (publ) ThermoFisher-medhvitt Thermo Fisher Scientific commenced on October 31, 2023 a Tender Offer for all shares in Olink Holding AB (publ). |
|
| October 31, 2023 |
Exhibit (a)(5)(A) October 17, 2023 The Board of Directors Olink Holding AB (publ) Uppsala Science Park SE-751 83 Uppsala Sweden Members of the Board of Directors: You have requested our opinion as to the fairness, from a financial point of view, to the holders of common shares, quota value SEK 2. |
|
| October 31, 2023 |
Exhibit (e)(14) Employment Contract Olink Proteomics AB 559046-8632 Uppsala (the “Company”) and Elias Berglund the “Employee”) have today entered into the following agreement regarding an employment at the Company. |
|
| October 31, 2023 |
Exhibit (d)(5) CERTAIN IDENTIFIED INFORMATION HAS BEEN REDACTED FROM THIS EXHIBIT, BECAUSE IT IS (1) NOT MATERIAL AND (2) THE TYPE THAT REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. |
|
| October 31, 2023 |
Exhibit (e)(16) OLINK HOLDING AB (publ) AMENDED AND RESTATED 2021 INCENTIVE AWARD PLAN 2023 INTERNATIONAL RESTRICTED STOCK UNIT AWARD GRANT NOTICE Olink Holding AB (publ), a Swedish public limited liability company (the “Company”), pursuant to its Amended and Restated 2021 Incentive Award Plan, as amended from time to time (the “Plan”), hereby grants to the holder listed below (the “Participant”), an award of restricted stock units (“Restricted Stock Units” or “RSUs”) in accordance with the percentage of the Participant’s base salary as notified to the Participant in the Equity section of the Company’s Bob HR system, at a per-unit price equal to the public price for one of the Company’s ADRs at market close on April 6, 2023. |
|
| October 31, 2023 |
INDEFINITE-TERM EMPLOYMENT CONTRACT Exhibit (e)(15) INDEFINITE-TERM EMPLOYMENT CONTRACT CONTRAT DE TRAVAIL A DUREE INDETERMINEE BETWEEN THE UNDERSIGNED : ENTRE : ⮚ Olink Proteomics SAS, Single-member simplified joint stock company with the SIREN number 919 080 143, Having its registered office at 9 rue du 4 septembre – 75002 Paris (France), ⮚ Olink Proteomics SAS, Société par actions simplifiée unipersonnelle dont le numéro SIREN est le 919 080 143, Ayant son siège social 9 rue du 4 septembre –75002 Paris (France), ⮚ Represented for the purpose hereof by Oskar Hjelm, President Représentée par M Oskar Hjelm. |
|
| October 31, 2023 |
Exhibit (e)(13) Employment Contract Olink Proteomics AB 559046-8632 Uppsala (the “Company”) and Anna Marsell (the “Employee”) have today entered into the following agreement regarding an employment at the Company. |
|
| October 31, 2023 |
Exhibit (d)(6) CERTAIN IDENTIFIED INFORMATION HAS BEEN REDACTED FROM THIS EXHIBIT, BECAUSE IT IS (1) NOT MATERIAL AND (2) THE TYPE THAT REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. |
|
| October 31, 2023 |
Exhibit (d)(11) CERTAIN IDENTIFIED INFORMATION HAS BEEN REDACTED FROM THIS EXHIBIT, BECAUSE IT IS (1) NOT MATERIAL AND (2) THE TYPE THAT REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. |
|
| October 31, 2023 |
Goldman Sachs Bank Europe SE, Sweden Bankfilial Exhibit (a)(5)(B) Goldman Sachs Bank Europe SE, Sweden Bankfilial Blasieholmsgatan 7 I 111 48 Stockholm I Sweden Tel: +46 (0)8 407 4900 PERSONAL AND CONFIDENTIAL October 17, 2023 Board of Directors Clink Holding AB (publ) Uppsala Science Park SE-751 83 Uppsala Sweden Ladies and Gentlemen: Attached is our opinion letter, dated October 17, 2023 ("Opinion Letter''),with respect to the fairness from a financial point of view to the holders (other than Thermo Fisher Scientific Inc. |
|
| October 31, 2023 |
TABLE OF CONTENTS Exhibit (a)(1)(A) OFFER TO PURCHASE FOR CASH All Outstanding Common Shares and All Outstanding American Depositary Shares, each representing one Common Share, of Olink Holding AB (publ) at $26. |
|
| October 31, 2023 |
Exhibit (a)(1)(G) This announcement is neither an offer to purchase nor a solicitation of an offer to sell Offer Securities (as defined below), and the provisions herein are subject in their entirety to the provisions of the Offer (as defined below). |
|
| October 31, 2023 |
Exhibit (a)(1)(D) OFFER TO PURCHASE FOR CASH ALL OUTSTANDING COMMON SHARES AND ALL OUTSTANDING AMERICAN DEPOSITARY SHARES, EACH REPRESENTING ONE COMMON SHARE OF OLINK HOLDING AB (publ) PURSUANT TO THE OFFER TO PURCHASE DATED OCTOBER 31, 2023 BY GOLDCUP 33985 AB (u. |
|
| October 31, 2023 |
Exhibit (d)(7) CERTAIN IDENTIFIED INFORMATION HAS BEEN REDACTED FROM THIS EXHIBIT, BECAUSE IT IS (1) NOT MATERIAL AND (2) THE TYPE THAT REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. |
|
| October 31, 2023 |
Exhibit (d)(4) June 25, 2023 CONFIDENTIAL Thermo Fisher Scientific Inc. 168 Third Avenue Waltham, Massachusetts 02451 Ladies and Gentlemen: In connection with proposed discussions between Olink Holding AB (publ) (the “Company”) and Thermo Fisher Scientific Inc. regarding a Company business update (such discussions, the “Business Update”) or the potential consideration by Thermo Fisher Scientific I |
|
| October 31, 2023 |
TRANSFER RESTRICTION AGREEMENT Exhibit (d)(3) CERTAIN IDENTIFIED INFORMATION HAS BEEN REDACTED FROM THIS EXHIBIT, BECAUSE IT IS (1) NOT MATERIAL AND (2) THE TYPE THAT REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. |
|
| October 31, 2023 |
Olink Tender Offer Launch Employee Letter from Olink CEO Exhibit (a)(5)(H) Olink Tender Offer Launch Employee Letter from Olink CEO Dear Colleagues, I am writing to share an update on the next step in our agreement to combine with Thermo Fisher Scientific. |
|
| October 31, 2023 |
OLINK HOLDING AB (publ) 2021 INCENTIVE AWARD PLAN 2023 INTERNATIONAL STOCK OPTION GRANT NOTICE Exhibit (e)(17) OLINK HOLDING AB (publ) 2021 INCENTIVE AWARD PLAN 2023 INTERNATIONAL STOCK OPTION GRANT NOTICE Olink Holding AB (publ), a Swedish public limited liability company (the “Company”), pursuant to its 2021 Incentive Award Plan, as may be amended from time to time (the “Plan”), hereby grants to the holder listed below (“Participant”), an option (“Option”) to purchase such number of Shares (as defined in the Plan) as set forth below. |
|
| October 31, 2023 |
Exhibit (a)(5)(H) FOR IMMEDIATE RELEASE Media Contact Information: Investor Contact Information: Sandy Pound Rafael Tejada Phone: 781-622-1223 Phone: 781-622-1356 E-mail: sandy. |
|
| October 31, 2023 |
Exhibit (e)(11) Sidan 1 av 5 Anställningsavtal Mellan Olink Proteomics AB 559046–8632 Uppsala (nedan kallat ”Bolaget”) och Ida Grundberg (nedan kallad den ”Anställde”) har denna dag träffats följande villkor för anställning i bolaget. |
|
| October 31, 2023 |
Exhibit (d)(10) RETENTION BONUS AGREEMENT This Retention Bonus Agreement (“Agreement”) is made and entered into as of October , 2023, by and between Thermo Fisher Scientific, Inc. |
|
| October 31, 2023 |
Exhibit (a)(1)(F) Stockholm, 31 October 2023 Dear Shareholders, nominee banks and other market participants holding shares in Olink Holding AB (publ) (“Olink”), Thermo Fisher Scientific Inc. |
|
| October 31, 2023 |
Exhibit (a)(1)(C) Acceptance Form for the public cash tender offer by Goldcup 33985 AB (u. |
|
| October 31, 2023 |
EX-99.(E)(8) 5 tm2328635d3ex99-e8.htm EXHIBIT (E)(8) Exhibit (e)(8) Olink Holding AB, reg. no 559189-7755, Uppsala (the "Company") and Jon Heimer, personal identity number, Stockholm, (the "Executive"), have today concluded the following EXECUTIVE AGREEMENT 1. Position and Start Date 1.1 The Executive is hereby employed as Chief Executive Officer/President (CEO) of the Company. This Agreement is e |
|
| October 31, 2023 |
Exhibit (e)(12) June 24, 2020 Carl Raimond Re: Offer of Employment Dear Carl: On behalf of Clink Proteomics, Inc. |
|
| October 31, 2023 |
HIGHLIGHTED EXECUTIVE BENEFITS Exhibit (d)(8) Mr. Carl Raimond Dear Carl Raimond, We are very excited about you joining Thermo Fisher Scientific Inc. following the expected consummation of our acquisition of Olink. This letter is intended to clarify provisions of your employment with us that will only become effective as of the date Olink becomes a wholly-owned subsidiary of Thermo Fisher Scientific Inc., or such earlier |
|
| October 31, 2023 |
Exhibit (d)(12) CERTAIN IDENTIFIED INFORMATION HAS BEEN REDACTED FROM THIS EXHIBIT, BECAUSE IT IS (1) NOT MATERIAL AND (2) THE TYPE THAT REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. |
|
| October 31, 2023 |
TABLE OF CONTENTS Exhibit (d)(1) PURCHASE AGREEMENT between THERMO FISHER SCIENTIFIC INC. |
|
| October 31, 2023 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 Olink Holding AB (publ) (Name of Subject Company) Olink Holding AB (publ) (Name of Person Filing Statement) American Depositary Shares, each representing one Common Share, quota va |
|
| October 31, 2023 |
Calculation of Filing Fee Table SCHEDULE TO (Rule 14d-100) OLINK HOLDING AB (PUBL) (Name of Subject Company (Issuer)) GOLDCUP 33985 AB (u. |
|
| October 31, 2023 |
Exhibit (d)(13) CERTAIN IDENTIFIED INFORMATION HAS BEEN REDACTED FROM THIS EXHIBIT, BECAUSE IT IS (1) NOT MATERIAL AND (2) THE TYPE THAT REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. |
|
| October 31, 2023 |
Exhibit (a)(1)(B) THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. |
|
| October 31, 2023 |
OLINK HOLDING AB (publ) 2021 INCENTIVE AWARD PLAN 2023 U.S. STOCK OPTION GRANT NOTICE Exhibit (e)(18) OLINK HOLDING AB (publ) 2021 INCENTIVE AWARD PLAN 2023 U.S. STOCK OPTION GRANT NOTICE Olink Holding AB (publ), a Swedish public limited liability company (the “Company”), pursuant to its 2021 Incentive Award Plan, as may be amended from time to time (the “Plan”), hereby grants to the holder listed below (“Participant”), an option (“Option”) to purchase such number of Shares (as def |
|
| October 31, 2023 |
Exhibit (a)(1)(E) OFFER TO PURCHASE FOR CASH ALL OUTSTANDING COMMON SHARES AND ALL OUTSTANDING AMERICAN DEPOSITARY SHARES, EACH REPRESENTING ONE COMMON SHARE OF OLINK HOLDING AB (publ) PURSUANT TO THE OFFER TO PURCHASE DATED OCTOBER 31, 2023 BY GOLDCUP 33985 AB (u. |
|
| October 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 OLINK HOLDING AB (PUBL) (Name of Subject Company (Issuer)) GOLDCUP 33985 AB (U.C.T. ORION ACQUISITION AB) (Offeror) a direct, wholly owned subsidiary of THERMO FISHER SCIENTIFIC INC. (Ultimate Parent of Offeror) Common |
|
| October 31, 2023 |
Exhibit (e)(9) Oskar Hjelm Confirmation of new compensation This letter is to confirm the changes to your employment with Olink Proteomics AB effective 1 April 2021 New Salary: 215 000 SEK per month Bonus 50% of your base salary All other employment conditions will stay the same. |
|
| October 31, 2023 |
EX-99.(E)(10) 7 tm2328635d3ex99-e10.htm EXHIBIT (E)(10) Exhibit (e)(10) Employment Contract Olink Proteomics AB 559046-8632 Uppsala (the "Company") and Rickard El Tarzi (the "Employee") have today entered into the following agreement regarding an employment at the Company. PERSONAL INFORMATION Name: Rickard El Tarzi Personal id #: The Company and the Employee are referred to individually as "Party |
|
| October 31, 2023 |
Exhibit (d)(9) NONCOMPETITION AGREEMENT THIS AGREEMENT, dated as of October 15, 2023, is made by and between Carl Raimond (the “Employee”), and Thermo Fisher Scientific Inc. |
|
| October 31, 2023 |
Exhibit (d)(2) CERTAIN IDENTIFIED INFORMATION HAS BEEN REDACTED FROM THIS EXHIBIT, BECAUSE IT IS (1) NOT MATERIAL AND (2) THE TYPE THAT REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. |
|
| October 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO-C (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or (13)(e)(1) of the Securities Exchange Act of 1934 OLINK HOLDING AB (PUBL) (Name of Subject Company (Issuer)) Thermo Fisher Scientific Inc. (Ultimate Parent of Offeror) American Depositary Shares, each representing one Common Share, quota value SEK 2. |
|
| October 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2023 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Salagaten 16A SE-753 30 Uppsala, Sweden (Address of principal ex |
|
| October 25, 2023 |
Exhibit 99.1 The following is an excerpt from the transcript of Thermo Fisher’s Q3 2023 earnings call held on October 25, 2023: Shortly after the close of the quarter we announced the agreement to acquire Olink, a company that is accelerating proteomics. Olink’s products enable leading academic researchers and the biopharmaceutical companies to gain an understanding of disease at the protein level |
|
| October 18, 2023 |
Exhibit 99.1 Execution Version PURCHASE AGREEMENT between THERMO FISHER SCIENTIFIC INC. and OLINK HOLDING AB (PUBL), dated as of October 17, 2023 TABLE OF CONTENTS ARTICLE I DEFINITIONS 1 Section 1.1 Certain Definitions 1 ARTICLE II THE OFFER 13 Section 2.1 The Offer 13 Section 2.2 Company Action 16 Section 2.3 Treatment of Equity Awards 17 Section 2.4 Further Actions 18 Section 2.5 Compulsory Red |
|
| October 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2023 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Salagaten 16A SE-753 30 Uppsala, Sweden (Address of principal ex |
|
| October 18, 2023 |
Exhibit 99.2 EXECUTION VERSION TENDER AND SUPPORT AGREEMENT This TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of October 17, 2023, is entered into by and among Thermo Fisher Scientific Inc., a Delaware corporation (“Parent”), each of the individuals or entities set forth on Schedule A (each, a “Shareholder”, including Jon Hindar, chairman of the Company Board, and Nicolas Roelofs, mem |
|
| October 18, 2023 |
TRANSFER RESTRICTION AGREEMENT Exhibit 99.3 EXECUTION VERSION TRANSFER RESTRICTION AGREEMENT This TRANSFER RESTRICTION AGREEMENT (this “Agreement”), dated as of October 17, 2023, is entered into by and between Thermo Fisher Scientific Inc., a Delaware corporation (“Parent”) and each of the individuals or entities set forth on Schedule A (each, a “Shareholder”). All terms used but not otherwise defined in this Agreement shall ha |
|
| October 17, 2023 |
TMO – OLK Partner / Supplier Letter Exhibit 99.4 TMO – OLK Partner / Supplier Letter October 17, 2023 Dear Valued Partner: As an important partner to Thermo Fisher, I am pleased to share that we recently announced an agreement to acquire Olink, a leading provider of next generation proteomics solutions. This announcement marks an exciting milestone for Thermo Fisher and furthers our commitment to serving science as we fulfill our Mi |
|
| October 17, 2023 |
Exhibit 99.5 TMO – OLK Customer Letter October 17, 2023 Dear Valued Customer: As an important Thermo Fisher customer, I am pleased to share that we recently announced an agreement to acquire Olink, a leading provider of next generation proteomics solutions. This announcement marks an exciting milestone for Thermo Fisher and furthers our commitment to serving science as we fulfill our Mission – ena |
|
| October 17, 2023 |
Exhibit 99.3 The following communication was posted by Thermo Fisher Scientific, Inc. (the “Company”) on X (formerly Twitter) on October 17, 2023. We are excited to announce that we have entered into an agreement to acquire @OlinkProteomics, a leading provider of next generation proteomics solutions. We look forward to welcoming their team to Thermo Fisher. Learn more in our Press Release: [Link t |
|
| October 17, 2023 |
Exhibit 99.4 Click here to enter text. OLK Partner / Supplier Letter October 17, 2023 Dear [INSERT PARTNER NAME // Valued Partner], I assume you have seen the press release. We are pleased to share that Olink has entered into an agreement to be acquired by Thermo Fisher Scientific, the world leader in serving science. This announcement marks the beginning of a new and exciting chapter for Olink. U |
|
| October 17, 2023 |
TMO – OLK Marc Email to All TMO Employees Exhibit 99.1 TMO – OLK Marc Email to All TMO Employees Marc N. Casper Chairman, President and Chief Executive Officer October 17, 2023 Dear Colleague: I am very pleased to share that Thermo Fisher has announced an agreement to acquire Olink, a company dedicated to accelerating proteomics. Olink is headquartered in Sweden with global operations and has approximately 600 employees. It offers leading |
|
| October 17, 2023 |
TMO – OLK LSG Letter from Gianluca Exhibit 99.2 TMO – OLK LSG Letter from Gianluca Gianluca Pettiti Executive Vice President October 17, 2023 Dear Colleague: I’m reaching out regarding the exciting announcement that Thermo Fisher made today about entering into an agreement to acquire Olink, a leading provider of next generation proteomics solutions. By now, you should have received an email from Marc Casper highlighting some of the |
|
| October 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO-C (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or (13)(e)(1) of the Securities Exchange Act of 1934 OLINK HOLDING AB (PUBL) (Name of Subject Company (Issuer)) Thermo Fisher Scientific Inc. (Ultimate Parent of Offeror) American Depositary Shares, each representing one Common Share, quota value SEK 2. |
|
| October 17, 2023 |
Exhibit 99.5 OLK Corporate Social Posts X Post #1 We are excited to take an important step forward in our journey as we enter into an agreement to combine with @ThermoFisherScientific, the world leader in serving science. Learn more in our Press Release: https://bit.ly/3s3Owm2 Post #2 Today we announced an agreement to combine with @ThermoFisherScientific, the world leader in serving science. Toge |
|
| October 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 Olink Holding AB (publ) (Name of Subject Company) Olink Holding AB (publ) (Name of Person Filing Statement) American Depositary Shares, each representing one Common Share, quota value SEK 2.431906612623020 per sha |
|
| October 17, 2023 |
false000009774500000977452023-10-172023-10-170000097745us-gaap:CommonStockMember2023-10-172023-10-170000097745tmo:Zero875NotesDue2031Member2023-10-172023-10-170000097745tmo:Zero125NotesDue2025Member2023-10-172023-10-170000097745tmo:One500NotesDue2039Member2023-10-172023-10-170000097745tmo:Three650NotesDue2034Member2023-10-172023-10-170000097745tmo:Zero750NotesDue2024Member2023-10-172023-10-1700000 |
|
| October 17, 2023 |
Olink All-Employee Letter from Olink CEO Exhibit 99.2 Olink All-Employee Letter from Olink CEO [Dear Colleagues / INSERT CUSTOMARY GREETING], Thanks to the hard work and dedication of this team, in just a few years Olink has grown rapidly from a small Uppsala-based growth company offering assays for a few hundred proteins, to a global organization advancing the field of proteomics. Today I’m excited to share that we have announced an agr |
|
| October 17, 2023 |
Exhibit 99.3 OLK Customer Letter October 17, 2023 Dear [INSERT CUSTOMER NAME // Valued Customer], I am pleased to share that Olink has entered into an agreement to be acquired by Thermo Fisher Scientific, the world leader in serving science. This announcement marks the beginning of a new and exciting chapter for Olink. Thermo Fisher is a mission-driven company and delivers an unrivaled combination |
|
| October 17, 2023 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Media Contact Information: Investor Contact Information: Sandy Pound Rafael Tejada Phone: 781-622-1223 Phone: 781-622-1356 E-mail: [email protected] E-mail: [email protected] Website: www.thermofisher.com Thermo Fisher Scientific to Acquire Olink, a Leader in Next-Generation Proteomics Enhances Thermo Fisher’s Capabilities in the High-Grow |
|
| October 17, 2023 |
Exhibit 99.1 Thermo Fisher Scientific to Acquire Olink, a Leader in Next-Generation Proteomics Enhances Thermo Fisher’s Capabilities in the High-Growth Proteomics Market with the Addition of Highly Differentiated Solutions Complements Existing Life Sciences and Mass Spectrometry Offerings, Accelerating Protein Biomarker Discovery and Providing Strong Synergy Opportunities WALTHAM, Mass. and UPPSAL |
|
| August 29, 2023 |
Olink to participate in September investor events Exhibit 99.1 Olink to participate in September investor events UPPSALA, Sweden, August 29, 2023 - Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that Company management will participate in the following investor events: •Goldman Sachs 20th Annual European Medtech and Healthcare Services Conference Thursday, September 7th at 7:15 am ET •Morgan Stanley 21st Annual Global Healthcare |
|
| August 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Uppsala Science Park SE-751 83 Uppsala, Sweden (Address of princi |
|
| August 9, 2023 |
Exhibit 99.2 INTERIM CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND OTHER COMPREHENSIVE INCOME (UNAUDITED) Three months ended June 30, Six months ended June 30, Amounts in thousands of U.S. Dollars Note 2023 2022 2023 2022 Revenue 4 $ 29,436 $ 27,514 $ 56,893 $ 50,191 Cost of goods sold (12,145) (10,444) (21,988) (19,804) Gross profit 17,292 17,070 34,905 30,387 Selling expenses (12,608) (10,588) |
|
| August 9, 2023 |
2Q 2023 earnings August 9, 2023 Olink Proteomics Vision Enable understanding of real-time human biology Mission Accelerate proteomics together Disclaimer This presentation contains express or implied "forward-looking statements," as defined under the Private Securities Litigation Reform Act of 1995, that involve substantial risks and uncertainties. |
|
| August 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Uppsala Science Park SE-751 83 Uppsala, Sweden (Address of princi |
|
| August 9, 2023 |
Olink reports second quarter 2023 financial results Exhibit 99.1 Olink reports second quarter 2023 financial results UPPSALA, Sweden, August 9, 2023 (GLOBE NEWSWIRE) - Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial results for the second quarter ended June 30, 2023. Highlights •Second quarter 2023 revenue totaled $29.4 million, representing year over year growth of 7.0% on a reported basis and 7.2% on a cons |
|
| July 26, 2023 |
PRIVILEGED AND CONFIDENTIAL July 26, 2023 Via Edgar U.S. Securities and Exchange Commission Division of Corporation Finance Office of Industrial Application and Services 100 F Street, N.E. Washington, D.C. 20549 Attention: Al Pavot and Jeanne Baker Re: Olink Holding AB (publ) Annual Report on Form 20-F Filed March 27, 2023 File No. 1-40277 Ladies and Gentlemen: This letter sets forth the response |
|
| July 13, 2023 |
Exhibit 99.1 Olink to report second quarter 2023 financial results on August 9, 2023, and to participate in the Canaccord Genuity 43rd Annual Growth Conference UPPSALA, Sweden, July 13, 2023 - Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced it will release financial results for the second quarter of 2023 before the market open on Wednesday, August 9, 2023. Company management will h |
|
| July 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2023 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Uppsala Science Park SE-751 83 Uppsala, Sweden (Address of principa |
|
| May 25, 2023 |
Olink to participate in June investor events Exhibit 99.1 Olink to participate in June investor events UPPSALA, Sweden, May 25, 2023 - Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that Company management will participate in the following investor events: •William Blair 43rd Annual Growth Stock Conference Tuesday, June 6th •Goldman Sachs 44th Annual Global Healthcare Conference Wednesday, June 14th at 2:00 pm PT / 5:00 pm |
|
| May 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2023 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Uppsala Science Park SE-751 83 Uppsala, Sweden (Address of principal |
|
| May 11, 2023 |
a2023q16-kdeck 1Q 2023 earnings May 11, 2023 Olink Proteomics Vision Enable understanding of real-time human biology Mission Accelerate proteomics together Exhibit 99. |
|
| May 11, 2023 |
Olink reports first quarter 2023 financial results Exhibit 99.1 Olink reports first quarter 2023 financial results UPPSALA, Sweden, May 11, 2023 (GLOBE NEWSWIRE) - Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial results for the first quarter ended March 31, 2023. Highlights •First quarter 2023 revenue totaled $27.5 million, representing year over year growth of 21% on a reported basis and 25% on a constant c |
|
| May 11, 2023 |
EX-99.2 3 a2023q16-kreporttemplatest.htm EX-99.2 Exhibit 99.2 INTERIM CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND OTHER COMPREHENSIVE INCOME (UNAUDITED) Three months ended March 31, Amounts in thousands of U.S. Dollars Note 2023 2022 Revenue 4 $ 27,457 $ 22,677 Cost of goods sold (9,843) (9,360) Gross profit 17,614 13,317 Selling expenses (11,995) (9,465) Administrative expenses (16,381) (14,3 |
|
| May 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2023 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Uppsala Science Park SE-751 83 Uppsala, Sweden (Address of principal |
|
| April 17, 2023 |
As filed with the Securities and Exchange Commission on April 17, 2023 As filed with the Securities and Exchange Commission on April 17, 2023 Registration No. |
|
| April 17, 2023 |
First Amendment to Olink Holding AB (publ) Amended and Restated 2021 Incentive Award Plan Exhibit 99.2 First Amendment to Olink Holding AB (publ) Amended and Restated 2021 Incentive Award Plan This First Amendment to Olink Holding AB (publ) Amended and Restated 2021 Incentive Award Plan (this “First Amendment”), made as of 14 March 2023, is made and adopted by Olink Holding AB (publ), a Swedish public limited liability company (the “Company”). Capitalized terms used but not otherwise d |
|
| April 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2023 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Uppsala Science Park SE-751 83 Uppsala, Sweden (Address of princip |
|
| April 17, 2023 |
Exhibit 107 Calculation of Filing Fee Table S-8 (Form Type) Olink Holding AB (publ) (Exact Name of Registrant as Specified in its Charter) Table 1—Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Shares, quota value approx. |
|
| April 17, 2023 |
Report from the Annual General Meeting of Olink Holding AB (publ) on 17 April 2023 Exhibit 99.1 Press release 17 April 2023 Report from the Annual General Meeting of Olink Holding AB (publ) on 17 April 2023 At the Annual General Meeting (the “AGM”) of Olink Holding AB (publ), reg. no 559189-7755, (the “Company”), on 17 April 2023 the AGM adopted, inter alia, the following resolutions. For more detailed information regarding the contents of the resolutions, please refer to the no |
|
| April 13, 2023 |
Olink to report first quarter 2023 financial results on May 11, 2023 Exhibit 99.1 Olink to report first quarter 2023 financial results on May 11, 2023 UPPSALA, Sweden, April 13, 2023 - Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced it will release financial results for the first quarter of 2023 before the market open on Thursday, May 11, 2023. Company management will host a conference call to discuss these results at 8:00 am ET. Investors intereste |
|
| April 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2023 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Uppsala Science Park SE-751 83 Uppsala, Sweden (Address of princip |
|
| March 27, 2023 |
Olink publishes 2022 annual report Exhibit 99.2 Olink publishes 2022 annual report UPPSALA, Sweden, March 27, 2023 (GLOBE NEWSWIRE) - Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that the Annual Report for 2022 is now available on the Company’s website at https://investors.olink.com/. About Olink Olink Holding AB (Nasdaq: OLK) is a company dedicated to accelerating proteomics together with the scientific communit |
|
| March 27, 2023 |
Exhibit 13.2 Certification by the Principal Executive Officer pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the annual report on Form 20-F of Olink Holding AB (publ) (the “Company”) for the year ended December 31, 2022, as filed with the U.S. Securities and Exchange Commission on the date hereof (the “Report”), I, Oskar H |
|
| March 27, 2023 |
Exhibit 99.1 The Board of Directors and the CEO of Olink Holding AB (publ) Corporate identity number 559189-7755 submit the following Annual report and consolidated financial statements for the financial year 1 January – 31 December 2022 Financial statements Olink Holding AB (publ) 559189-7755 Directors’ report 2 Consolidated statement of income and other comprehensive income for the year ended De |
|
| March 27, 2023 |
a410firstamendmenttoleas DocuSign Envelope ID: A6CF8830·1AE6-499B-9E69-01854735E629 CERTAIN INFORMATION IN THIS DOCUMENT, MARKED BY -HAS BEEN EXCLUDED PURSUANT TO THE INSTRUCTIONS TO FORM 20- F AND SEC RULES AND REGULA TIO NS. |
|
| March 27, 2023 |
Exhibit 13.1 Certification by the Principal Executive Officer pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 In connection with the annual report on Form 20-F of Olink Holding AB (publ) (the “Company”) for the year ended December 31, 2022, as filed with the U.S. Securities and Exchange Commission on the date hereof (the “Report”), I, Jon Hei |
|
| March 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT O |
|
| March 27, 2023 |
EX-2.5 2 a25descriptionofsecuriti.htm EX-2.5 Exhibit 2.5 Description of Securities DESCRIPTION OF SHARE CAPITAL AND ARTICLES OF ASSOCIATION Introduction Set forth below is a summary of certain information concerning Olink Holding AB (publ)'s (“us,” “our,” “we” or the “Company”) share capital as well as a description of certain provisions of our articles of association and relevant provisions of th |
|
| March 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2023 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Uppsala Science Park SE-751 83 Uppsala, Sweden (Address of princip |
|
| March 27, 2023 |
Exhibit 12.1 Certification by the Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Jon Heimer, certify that: 1.I have reviewed this annual report on Form 20-F of Olink Holding AB (publ); 2.Based on my knowledge, this report does not contain any untrue statement of a material fact or |
|
| March 27, 2023 |
a48englishsummaryoflease English Summary Lease Agreement 54304-2031 Exhibit 4.8 The Lease Agreement (hereinafter referred to as the “Lease”) was entered into on 2021-05-12 by and between: I. Uppsala Kvarngärdet 27:2 AB (559226-7651) a limited partnership company with an address at c/o Bonnier Fastigheter AB Box 3167 103 63 Stockholm (“Landlord”) and II. Olink Proteomics AB, Dag Hammarskjölds väg 5 |
|
| March 27, 2023 |
a41olinksupplyandlicense Exhibit 4.1 /s/ Jon Heimer CEO |
|
| March 27, 2023 |
a49leaseagreementdatedap DocuSign Envelope ID: B8B127E0-0F36-4A12-AAC3-CA946FB1D5F4 1 LEASE By and Between JC/SMP WALTHAM OWNER, LLC, (“Landlord”) And OLINK PROTEOMICS INC. |
|
| March 27, 2023 |
Consent of Independent Registered Public Accounting Firm. Exhibit 15.1 Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the following Registration Statements: a.Registration Statement (Form S-8 No. 333-254844) b.Registration Statement (Form S-8 No. 333-264181) c.Registration Statement (Form F-3 No. 333-269285) of our report dated March 27, 2023, with respect to the consolidated financial statements |
|
| March 27, 2023 |
Exhibit 12.2 Certification by the Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Oskar Hjelm, certify that: 1.I have reviewed this annual report on Form 20-F of Olink Holding AB (publ); 2.Based on my knowledge, this report does not contain any untrue statement of a material fact o |
|
| March 27, 2023 |
Consent of Öhrlings PricewaterhouseCoopers AB, independent registered public accounting firm. Exhibit 15.3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (No. 333-269285) and Form S-8 (Nos. 333-264181 and 333-254844) of Olink Holding AB (publ) of our report dated March 17, 2022 relating to the financial statements which appears in this Form 20-F. /s/ Öhrlings PricewaterhouseCoopers AB S |
|
| March 21, 2023 |
Bruno Rossi joins Olink as Chief Commercial Officer Exhibit 99.1 Bruno Rossi joins Olink as Chief Commercial Officer UPPSALA, Sweden, March 21, 2023 (GLOBE NEWSWIRE) - Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced the appointment of life sciences industry veteran Bruno Rossi to the role of Chief Commercial Officer (CCO), effective immediately. Mr. Rossi will lead the Company’s global commercial organization including Sales, Market |
|
| March 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2023 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Uppsala Science Park SE-751 83 Uppsala, Sweden (Address of princip |
|
| March 15, 2023 |
Total number of stock options/RSUs within the category Exhibit 99.1 This is a translation of the Swedish original. In case of any discrepancies between this translation and the Swedish original, the latter shall prevail. Notice to attend the Annual General Meeting of Olink Holding AB (publ) The shareholders of Olink Holding AB (publ) (the “Company” or “Olink”), reg. no. 559189-7755, are hereby given notice to attend the Annual General Meeting to be he |
|
| March 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2023 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Uppsala Science Park SE-751 83 Uppsala, Sweden (Address of princip |
|
| February 21, 2023 |
Three months ended December 31 Exhibit 99.1 Olink reports fourth quarter and full year 2022 financial results UPPSALA, Sweden, February 21, 2023 (GLOBE NEWSWIRE) - Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2022. Highlights •Fourth quarter revenue totaled $57.9 million, representing year over year growth of 33% on a repo |
|
| February 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2023 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Uppsala Science Park SE-751 83 Uppsala, Sweden (Address of prin |
|
| February 21, 2023 |
olk4q22xdeck 4Q 2022 earnings February 21, 2023 Olink Proteomics Vision Enable understanding of real-time human biology Mission Accelerate proteomics together Exhibit 99. |
|
| February 14, 2023 |
OLK / Olink Holding AB (publ) / PRICE T ROWE ASSOCIATES INC /MD/ Passive Investment SC 13G/A 1 olk13gadec22.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) OLINK HOLDING AB - ADR (Name of Issuer) ADR (Title of Class of Securities) 680710100 (CUSIP NUMBER) December 31, 2022 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant t |
|
| January 23, 2023 |
Olink Holding AB (publ) launches public offering of American Depositary Shares EX-99.1 4 tm233507d10ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Olink Holding AB (publ) launches public offering of American Depositary Shares Uppsala, Sweden – January 18, 2023 – Olink Holding AB (publ) (Nasdaq: OLK) (“Olink” or the “Company”), today announced the launch of a public offering of 5,831,028 American Depositary Shares, each representing one common share of the Company (the “ADSs”), consist |
|
| January 23, 2023 |
EX-1.1 2 tm233507d10ex1-1.htm EXHIBIT 1.1 Exhibit 1.1 Execution Version Olink Holding AB (publ) 5,831,028 American Depositary Shares representing 5,831,028 Common Shares, quota value SEK 2.431906612470569 per share Underwriting Agreement January 18, 2023 Goldman Sachs Bank Europe SE J.P. Morgan Securities LLC As representatives (the “Representatives”) of the several Underwriters named in Schedule |
|
| January 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of January 2023 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Translation of registrant’s name into English) Uppsala Science Park SE-751 83 Uppsala, Sweden (Address of principal executiv |
|
| January 23, 2023 |
Olink Holding AB (publ) announces pricing of public offering of American Depositary Shares Exhibit 99.2 Olink Holding AB (publ) announces pricing of public offering of American Depositary Shares Uppsala, Sweden – January 18, 2023 – Olink Holding AB (publ) (Nasdaq: OLK) (“Olink” or the “Company”), today announced the pricing of a public offering of 5,831,028 American Depositary Shares, each representing one common share of the Company (the “ADSs”), consisting of 4,250,000 ADSs offered by |
|
| January 20, 2023 |
Exhibit 107 Calculation of Filing Fee Tables 424B5 (Form Type) Olink Holding AB (publ) (Exact Name of Registrant as Specified in its Charter) Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Newly Registered Securities Fees to Be Paid Equity Common Share, quota value approx. |
|
| January 20, 2023 |
5,831,028 American Depositary Shares Representing 5,831,028 Common Shares 424B5 1 tm233507-8424b5.htm 424B5 TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(5) Registration No. 333-269285 PROSPECTUS SUPPLEMENT (To prospectus dated January 18, 2023) 5,831,028 American Depositary Shares Representing 5,831,028 Common Shares Olink Holding AB (publ) is offering 4,250,000 American Depositary Shares, or ADSs to be sold in the offering. The selling shareholders identified in |
|
| January 18, 2023 |
Subject to completion, dated January 18, 2023 424B5 1 tm233507-5424b5.htm 424B5 TABLE OF CONTENTS The information in this preliminary prospectus supplement and the accompanying base prospectus is not complete and may be changed. This preliminary prospectus supplement and the accompanying base prospectus are not an offer to sell these securities, and are not soliciting an offer to buy these securities, in any jurisdiction where the offer or sa |
|
| January 18, 2023 |
Form F-3ASR (File No. 333- 269285) F-3ASR 1 tm233507-1f3asr.htm F-3ASR TABLE OF CONTENTS As filed with the Securities and Exchange Commission on January 18, 2023. Registration Statement No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form F-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Olink Holding AB (publ) (Exact name of registrant as specified in its charter) Not Applicable (T |
|
| January 18, 2023 |
Form of Subordinated Indenture. Exhibit 4.8 OLINK HOLDING AB (PUBL) FORM OF SUBORDINATED INDENTURE Dated as of [ ], 20[ ] [ ] Trustee TABLE OF CONTENTS Page ARTICLE I DEFINITIONS AND INCORPORATION BY REFERENCE 1 Section 1.01 Definitions 1 Section 1.02 Other Definitions 5 Section 1.03 Incorporation by Reference of Trust Indenture Act 5 Section 1.04 Rules of Construction 6 ARTICLE II THE SECURITIES 6 Section 2.01 Issuable in Se |
|
| January 18, 2023 |
Exhibit 107 Calculation of Filing Fee Table FORM F-3 (Form Type) Olink Holding AB (publ) (Exact Name of Registrant as Specified in its Charter) Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Number Carry Forward Initial effective date Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward Newly Registered Securities Fees to Be Paid Equity Common Share, quota value approx. |
|
| January 18, 2023 |
Exhibit 4.7 OLINK HOLDING AB (PUBL) FORM OF SENIOR INDENTURE Dated as of [ ], 20[ ] [ ] Trustee Table of Contents Page Article I DEFINITIONS AND INCORPORATION BY REFERENCE 1 Section 1.01 Definitions 1 Section 1.02 Other Definitions 5 Section 1.03 Incorporation by Reference of Trust Indenture Act 5 Section 1.04 Rules of Construction 6 Article II THE SECURITIES 6 Section 2.01 Issuable in Series 6 Se |
|
| January 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2023 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Uppsala Science Park SE-751 83 Uppsala, Sweden (Address of princ |
|
| January 11, 2023 |
EX-99.1 2 olkjpmorganpresentation2.htm EX-99.1 Olink Proteomics Jon Heimer, CEO JP Morgan Healthcare Conference January 11, 2023 San Francisco, CA Exhibit 99.1 Important notice This presentation may contain certain forward-looking statements and opinions. Forward-looking statements are statements that do not relate to historical facts and events and such statements and opinions pertaining to the f |
|
| January 9, 2023 |
6-K 1 cover6kxjanuaryx2023xforx.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2023 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Uppsala Science Park SE- |
|
| January 9, 2023 |
Exhibit 99.1 Olink announces preliminary unaudited revenue for the fourth quarter and full year 2022 and provides outlook for 2023 UPPSALA, Sweden, January 09, 2023 - Olink Holding AB (publ) (“Olink” or the “Company”) (Nasdaq: OLK), today announced preliminary unaudited revenue for the fourth quarter and year ended December 31, 2022, and additional selected unaudited performance metrics. Full year |
|
| December 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2022 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Uppsala Science Park SE-751 83 Uppsala, Sweden (Address of prin |
|
| December 29, 2022 |
Olink to participate in the 41 EX-99.1 2 olkjpm23x6kxpr.htm EX-99.1 Exhibit 99.1 Olink to participate in the 41st Annual JP Morgan Healthcare Conference UPPSALA, Sweden, December 29, 2022 - Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced its participation in the 41st Annual JP Morgan Healthcare Conference. Company management will present on Wednesday, January 11th, 2023 at 7:30 am PT. A live and archived webcas |
|
| November 10, 2022 |
1 Olink press release I Third quarter 2022 report Exhibit 99.1 Olink reports third quarter 2022 financial results UPPSALA, Sweden, November 10, 2022 (GLOBE NEWSWIRE) - Olink Holding AB (publ) (?Olink?) (Nasdaq: OLK) today announced its unaudited financial results for the third quarter of 2022. Highlights ? Third quarter 2022 revenue totaled $31.8 million, represenWng year over year growth of 59% o |
|
| November 10, 2022 |
3Q 2022 earnings November 10, 2022 Olink Proteomics Vision Enable understanding of real-time human biology Mission Accelerate proteomics together Disclaimer This presentation may contain certain forward-looking statements and opinions. |
|
| November 10, 2022 |
6-K 1 cover6kxtoxbexaddedxtox6k.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2022 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Uppsala Science Park SE |
|
| November 10, 2022 |
Three months ended September 30, Exhibit 99.2 INTERIM CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND OTHER COMPREHENSIVE INCOME (UNAUDITED) Three months ended September 30, Nine months ended September 30, Amounts in thousands of U.S. Dollars Note 2022 2021 2022 2021 Revenue 4 $ 31,772 $ 19,974 $ 81,963 $ 51,290 Cost of goods sold (10,785) (7,565) (30,589) (18,384) Gross profit 20,987 12,409 51,374 32,906 Selling expenses (11,240 |
|
| November 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2022 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Uppsala Science Park SE-751 83 Uppsala, Sweden (Address of prin |
|
| November 1, 2022 |
Olink to participate in November investor events Exhibit 99.1 Olink to participate in November investor events UPPSALA, Sweden, November 01, 2022 - Olink Holding AB (publ) (?Olink?) (Nasdaq: OLK), today announced that Company management will participate in the following investor events: ? Olink Investor Day 2022 Monday, November 14th at 11:00 am ET ? Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum Thursday, November 17 |
|
| October 13, 2022 |
6-K 1 tm2227952d16k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2022 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Uppsala Science Park SE-751 83 |
|
| October 13, 2022 |
Olink to report third quarter 2022 financial results on November 10, 2022 Exhibit 99.1 Olink to report third quarter 2022 financial results on November 10, 2022 UPPSALA, Sweden, October 13, 2022 - Olink Holding AB (publ) (?Olink?) (Nasdaq: OLK) today announced it will release financial results for the third quarter of 2022 before the market open on Thursday, November 10, 2022. Company management will host a conference call to discuss these results at 8:00 am ET. Investo |
|
| August 31, 2022 |
Olink strengthens management team for continued leadership in the modern proteomics era Exhibit 99.1 Olink strengthens management team for continued leadership in the modern proteomics era UPPSALA, Sweden, August 31, 2022 (GLOBE NEWSWIRE) - Olink Holding AB (publ) (?Olink?) (Nasdaq: OLK) today announced several appointments in its leadership structure. Olink Chief Commercial Officer (CCO) Carl Raimond will be appointed President, effective upon the hiring of a new CCO, which is expec |
|
| August 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2022 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Uppsala Science Park SE-751 83 Uppsala, Sweden (Address of princi |
|
| August 30, 2022 |
Olink to participate in September investor conferences Exhibit 99.1 Olink to participate in September investor conferences UPPSALA, Sweden, August 30, 2022 - Olink Holding AB (publ) (?Olink?) (Nasdaq: OLK), today announced that Company management will participate in the following investor conferences: ? Goldman Sachs Medtech and Healthcare Services Conference Wednesday, September 7th at 6:30 am ET ? Morgan Stanley Healthcare Conference Monday, Septemb |
|
| August 30, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2022 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Uppsala Science Park SE-751 83 Uppsala, Sweden (Address of princi |
|
| August 11, 2022 |
Exhibit 99.2 INTERIM CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND OTHER COMPREHENSIVE INCOME (UNAUDITED) Three months ended June 30, Six months ended June 30, Amounts in thousands of U.S. Dollars Note 2022 2021 2022 2021 Revenue 4 $ 27,514 $ 17,688 $ 50,191 $ 31,316 Cost of goods sold (10,444 ) (5,823 ) (19,804 ) (10,819 ) Gross profit 17,070 11,865 30,387 20,497 Selling expenses (10,588 ) (6,9 |
|
| August 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2022 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Uppsala Science Park SE-751 83 Uppsala, Sweden (Address of princi |
|
| August 11, 2022 |
Exhibit 99.3 August 11, 2022 Olink Proteomics Vision Enable understanding of real - time human biology Mission Accelerate proteomics together Disclaimer This presentation may contain certain forward - looking statements and opinions . Forward - looking statements are statements that do not relate to historical facts and events and such statements and opinions pertaining to the future that, for exa |
|
| August 11, 2022 |
Exhibit 99.1 Olink reports second quarter 2022 financial results UPPSALA, Sweden, August 11, 2022 (GLOBE NEWSWIRE) - Olink Holding AB (publ) (?Olink?) (Nasdaq: OLK) today announced its unaudited financial results for the second quarter of 2022. Highlights ? Second quarter 2022 revenue totaled $27.5 million, representing year over year growth of 56% on a reported basis and 62% on a constant currenc |
|
| July 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2022 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Uppsala Science Park SE-751 83 Uppsala, Sweden (Address of principa |
|
| July 14, 2022 |
Olink to report second quarter 2022 financial results on August 11, 2022 Exhibit 99.1 Olink to report second quarter 2022 financial results on August 11, 2022 UPPSALA, Sweden, July 14, 2022 - Olink Holding AB (publ) (?Olink?) (Nasdaq: OLK) today announced it will release financial results for the second quarter of 2022 before the market open on Thursday, August 11, 2022. Company management will host a conference call to discuss these results at 8:00 am ET. Investors in |
|
| June 1, 2022 |
6-K 1 tm2217296d16k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2022 Commission File Number: 001-40277 OLINK HOLDING AB (PUBL) (Exact Name of Registrant as Specified in its Charter) Uppsala Science Park SE-751 83 Upp |
